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Abstract
The developmental course of daily functioning prior to first psychosis-onset remains poorly 
understood. This study explored age-related periods of change in social and role functioning. The 
longitudinal study included youth (aged 12–23, mean follow-up years = 1.19) at clinical high risk 
(CHR) for psychosis (converters [CHR-C], n = 83; nonconverters [CHR-NC], n = 275) and a 
healthy control group (n =164). Mixed-model analyses were performed to determine age-related 
differences in social and role functioning. We limited our analyses to functioning before psychosis 
conversion; thus, data of CHR-C participants gathered after psychosis onset were excluded. In 
controls, social and role functioning improved over time. From at least age 12, functioning in CHR 
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was poorer than in controls, and this lag persisted over time. Between ages 15 and 18, social 
functioning in CHR-C stagnated and diverged from that of CHR-NC, who continued to improve 
( p = .001). Subsequently, CHR-C lagged behind in improvement between ages 21 and 23, further 
distinguishing them from CHR-NC ( p < .001). A similar period of stagnation was apparent for 
role functioning, but to a lesser extent ( p = .007). The results remained consistent when we 
accounted for the time to conversion. Our findings suggest that CHR-C start lagging behind CHR-
NC in social and role functioning in adolescence, followed by a period of further stagnation in 
adulthood.
Disability in people with schizophrenia is evident in multiple areas of functioning, such as 
the quality of social contact and the fulfillment of roles at school or work (Green, Llerena, & 
Kern, 2015; Harvey et al., 2012). Although the importance of impaired social and role 
functioning as fundamental components of schizophrenia have been increasingly 
acknowledged (Burns & Patrick, 2007), little is known about their exact developmental 
course.
Studies of intellectual ability in schizophrenia indicate a slower increase in functioning in 
individuals who later develop the illness relative to the more rapid growth of healthy 
individuals (Reichenberg et al., 2010), indicating that cognitive abilities of future 
schizophrenia patients do increase over time, but with a pace slower than that of those who 
will never develop the illness. This finding is in congruence with the neurodevelopmental 
model, in which it is assumed that premorbid deficits in schizophrenia result from early 
neurodevelopmental disturbances, making it difficult to keep up with the “normal” 
functional growth that occurs later in life (Murray, O’Callaghan, Castle, & Lewis, 1992; 
Schmidt-Kastner, van Os, Esquivel, Steinbusch, & Rutten, 2012; Weinberger, 1987). The 
decade between early adolescence and young adulthood is specifically critical in this regard, 
as it has been suggested to represent a period during which growing societal/environmental 
challenges may negatively impact the final stages of brain maturation (Selemon & Zecevic, 
2015; Weinberger, 1987).
In individuals who later develop schizophrenia, increasing deviations relative to the healthy 
population, prior to illness onset, have also been observed at the level of social and 
academic/vocational functioning (referred to as role functioning; Cole, Apud, Weinberger, & 
Dickinson, 2012; Horton, Tarbox, Olino, & Haas, 2015; Shapiro et al., 2009). Extensive 
work in this field stems from the 1950s, when Dr. Philips created the empirically derived 
Premorbid Adjustment Scale to retrospectively assess premorbid social and role functioning 
levels in patients diagnosed with schizophrenia (Phillips, 1953). Studies using the scale have 
since pointed to considerable heterogeneity, but overall it tends to show growing levels of 
premorbid social impairment in the phases closer to the illness (e.g., Allen, Frantom, 
Strauss, & van Kammen, 2005; Hafner, Nowotny, Loffler, an der Heiden, & Maurer, 1995; 
Monte, Goulding, & Compton, 2008; Strauss et al., 2012). Poorer premorbid functioning 
scores were shown to be associated with worse symptom course and overall severity of 
illness (Garmezy & Rodnick, 1959).
However, these previous studies generally used retrospective designs, introducing 
methodological limitations, such as recall biases. Although one recent population-based 
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study showed a very similar pattern to the famous retrospective ABC studies (Hafner, 
Loffler, Maurer, Hambrecht, & an der Heiden, 1999), with increasing impairment compared 
to the general population in individuals tested closer to first hospitalization, this study 
included only one data point per individual (Velthorst et al., 2015). Collectively, these 
studies seem to point toward growing functional impairment over time, but longitudinal 
prospective studies are needed to confirm cross-sectional observations.
In addition, relatively little is known about the functional trajectories in the years following 
identification of risk of psychosis. Studying social and role functioning in this clinical high 
risk (CHR) phase is important, as it may provide important clues about the early 
developmental precursors of schizophrenia (Lin, Wood, & Yung, 2013). In most CHR 
studies carried out thus far, functional impairment is typically viewed as a single construct 
(e.g., as assessed with a single global assessment of functioning summary score; see Cotter 
et al., 2014), but distinct developmental trajectories may characterize different functional 
domains (Harvey et al., 2012). Previous studies from our group showed that, while 
impairments in both role and social functioning are persistent in individuals at CHR for 
psychosis (Addington, Cornblatt, et al., 2011), only deficits in the latter domain differentiate 
between those who eventually do and do not convert to psychosis (Cannon et al., 2008; 
Cornblatt et al., 2012), potentially suggestive of a differential developmental trajectory. 
Clarification of this matter is particularly important from the perspective of treatment of 
these different components of functional impairment.
In the present study, we explored if there are important periods during which impairments in 
the two key components of community functioning (social functioning and role functioning) 
start to become more pronounced in those who convert to psychosis. We compared the 
developmental trajectories of the two domains among CHR individuals who later converted 
to psychosis (CHR-C), CHR individuals who did not convert over a 2.5-year follow-up 
period (CHR-NC), and a healthy comparison group. More specifically, we examined 
whether the increased impairments over time in social and role functioning previously 
observed in CHR-C could be attributed to (age-related periods of) stagnation, delayed 
growth, or decline in functioning.
Methods
Subjects
We used data from 358 CHR and 164 healthy individuals (311 males, 211 females; baseline 
age: M = 17.37, SD = 3.0) who were participants in the North American Prodrome 
Longitudinal Study Phase 1 (NAPLS-1; Cannon et al., 2008) and/or the ongoing Center for 
Assessment and Prevention of Prodromal States (CAPPS) study at the University of 
California Los Angeles (UCLA) Semel Institute, and who had their baseline assessment in 
the decade between early adolescence and early adulthood (ages 12–23). Table 1 provides a 
detailed description of the baseline demographic and clinical characteristics broken down by 
group status. Forty-two percent of our sample (n = 217) was recruited as part of the CAPPS 
study. Of those, 41 (36 CHR, 5 controls) also participated in NAPLS-1. The other 176 
CAPPS participants were recruited after the establishment of the NAPLS-1 cohort. CAPPS 
and NAPLS-1 used identical inclusion criteria and study designs; all participants (CHR and 
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controls) were seen at 6-month intervals and prospectively followed for up to 2.5 years. At 
the UCLA Semel Institute, the same interviewers performed all clinical interviews and 
symptom ratings for both CAPPS and NAPLS-1.
CHR participants were help-seeking individuals who met criteria for one of three CHR 
categories, as assessed with the Structured Interview for Prodromal Syndromes (SIPS; 
McGlashan, Walsh, & Woods, 2010) by experienced MA/ PhD level clinicians: attenuated 
psychotic symptoms; transient, recent-onset psychotic symptoms; or a substantial drop in 
functioning in conjunction with schizotypal personality disorder or a first-degree relative 
with psychosis. Participants were excluded for current or past diagnosis of an Axis I 
psychotic disorder, including affective psychoses, as determined by the Structured Clinical 
Interview for the DSM-IV (SCID; First, Spitzer, Gibbon, & Williams, 1997). Approximately 
96% of the CHR participants met initial eligibility based on attenuated positive symptoms, 
and 4% met initial eligibility based on brief intermittent psychotic symptoms. While only 2 
(<1%) patients were ascertained as prodromal exclusively in the genetic risk and 
deterioration category, 12% had a comorbid attenuated positive symptoms–genetic risk and 
deterioration prodromal diagnosis.
The typically developing control sample, matched on age to the CHR sample, did not meet 
CHR criteria or DSM-IV criteria for any major psychiatric disorder. Additional exclusion 
criteria for all participants were as follows: neurological disorder, drug/alcohol abuse or 
dependence within the past 6 months, insufficient English fluency, and/or IQ below 70 (see 
(Addington et al., 2007, for more details regarding inclusion/ exclusion criteria and 
diagnostic reliability procedures). The institutional review boards of the participating sites 
approved study protocols and informed consent documents.
Measures
Symptomatology—The SIPS and the Scale for Assessment of Prodromal Syndromes 
(McGlashan et al., 2010) were used to assess CHR criteria, severity of attenuated positive 
symptoms and negative symptoms, and to define conversion to psychosis (Cannon et al., 
2008). Symptom domain scores were determined by the sum of symptom severity scores 
within each domain (positive, negative, disorganized, and general symptoms). Full details 
regarding SIPS criteria, reliability, and consensus procedures are described elsewhere 
(Addington et al., 2007; Meyer et al., 2005). The SCID (First et al., 1997) was used to 
establish current and past DSM IV Axis 1 diagnoses. Estimated full-scale IQ scores were 
derived from the Vocabulary and Block Design Tests of the Wechsler Intelligence Scale for 
Children—Third Edition (Wechsler, 1991) for individuals younger than 16 years and from 
the Wechsler Adult Intelligence Scale—Revised (Wechsler, 1981) for individuals 16 years or 
older (Carrion et al., 2013).
Social and role functioning—Social and role functioning were assessed using the GF: 
Social Scale and the GF: Role Scale (Cornblatt et al., 2012), two scales specifically designed 
to detect change in functioning in at-risk adolescents and young adults who are not as 
severely impaired as more chronic patients. The scales were initially validated as part of 
collaboration between the Zucker Hillside and UCLA sites, but later used as the common 
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social/role measures across NAPLS-1 sites (Cornblatt et al., 2012). The GF: Social Scale 
assesses peer relationships, peer conflict, age appropriate intimate relationships, and 
involvement with family members. The GF: Role Scale assesses performance and amount of 
support needed in one’s specific roles (i.e., school/work). Scores of both scales range from 1 
to 10 (with higher scores indicating better functioning). In the present study, we made use of 
the “current” functioning scores, that is, functioning levels in the month preceding 
assessment. Ratings for each scale were based on best estimates derived from all available 
information, an approach that has been shown to yield high interrater reliability scores 
(Cannon et al., 2008; Cornblatt et al., 2007).
Follow-up procedure
All 6-month interval follow-up interviews included SIPS ratings and the two global 
functioning scales. Conversion to psychosis was defined as the presence of a psychotic-level 
positive symptom (a score of 6 with a minimum duration of 1 week). For the majority of the 
cases, a follow-up SCID interview was conducted at the time of conversion to additionally 
determine DSM-IV diagnosis of psychotic disorder.
Statistical analyses
Because we were specifically interested in the period between early adolescence and early 
adulthood, and the number of data points per age group (specifically for converters) was 
substantially lower after this period, we restricted our analyses to participants aged 12–23 
years. We included only those participants who had data on social and role functioning, and 
IQ scores available. We limited our analyses to data collected on functioning prior to first 
onset of psychosis only; thus, data from CHR-C youth gathered after first psychosis onset 
was excluded. Interdependence between the two functional domains (i.e., shared variance 
between deficits in role and social functioning) was examined with partial correlations, 
controlling for age, gender, and IQ. We used regression analyses to examine the association 
between functional impairment, age at baseline, and time-to-conversion. Differences in 
baseline demographic characteristics, baseline symptoms (positive, negative, disorganized, 
or general), IQ, and social and role functioning between the control group, CHR-NC, and 
CHR-C individuals were examined with regression analyses for continuous variables, and 
chi-square tests for dichotomous variables.
Functioning data from the 358 CHR and 164 healthy individuals included in our study (159 
with 1 assessment, 363 with >1 assessment, range = 1–5) yielded 1,275 observations 
(including first assessment) to construct developmental trajectories. There were a 
significantly higher number of dropouts after first assessment among healthy individuals 
(43.3%; n = 71) versus in the CHR cohort (24.6%; n = 88). Some follow-up assessments 
were not included in the analyses as the participant aged-out of our age window: 9 
participants had turned 24 by the time of the second assessment, another 4 by the time of the 
third, 2 by the time of the fourth, and 3 more by the time of the fifth assessment. CHR 
individuals with only one assessment were comparable to those with >1 on all clinical and 
functional measures and most demographic characteristics, but were marginally older (17.6 
vs. 17.0; t = 1.98, p = .049). Healthy individuals with only one assessment did not differ 
from those with >1 on functional measures and demographic characteristics, but had 
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significantly less positive ( p < .001), general ( p = .023), and disorganization symptoms ( p 
= .013).
Developmental trajectories of social and role functioning were analyzed separately with 
multilevel linear modeling analyses (Statacorp 14; StataCorp, 2014), taking multiple 
observations per individual into account. We explored the different functioning 
developmental trajectories per status group by entering age of assessment as an independent 
variable, and functioning score as the dependent variable in the model (controlling for IQ 
and gender). Both the main effect of group (CHR-NC, CHR-C, and controls) and the 
Group×Age interaction were effects of interest: a group main effect only would be 
suggestive of a static group difference, whereas a Group×Age interaction would be 
suggestive of stagnation, faster growth, or decline in functioning in one group compared to 
other groups.
We subsequently explored whether there were specific periods in the functional development 
of future converters that distinguished them from nonconverters by subdividing all social and 
role functioning assessments into age bands that capture different developmental epochs: 
early adolescence (ages 12–15 years), middle to late adolescence (15–18 years), young 
adulthood (18–21 years), and adulthood (21–23 years). We performed multilevel linear 
modeling analyses for each age band to identify time periods when levels of functioning in 
the CHR-C group started to diverge from the CHR-NC. We controlled for gender and IQ in 
these analyses as well.
To explore whether the baseline severity of symptoms attenuated our findings, all analyses 
were repeated controlling for positive, negative, general, and disorganization symptoms.
Results
Of the 358 CHR participants, 83 converted (23.2%) to a psychotic disorder within the 
follow-up period. Diagnostic outcome was available for 70 converters (84.3%). Of those, 36 
(51.4%) received a diagnosis in the schizophrenia spectrum (schizophrenia, n = 18; 
schizophreniform, n = 11; schizoaffective, n = 7), 9 (12.9%) were diagnosed with a mood 
disorder with psychotic features, 19 (27.1%) with a psychosis not otherwise specified, 4 
(5.7%) with a brief psychotic episode, and 2 (2.9%) with a delusional disorder.
Among those who converted, the mean time from baseline assessment to conversion to 
psychosis was 0.88 years (~10 months; SD = 0.81). Average time of follow-up assessment 
for the remainder of the sample was 1.19 years (SD = 0.97). Time to conversion was not 
significantly associated with social and role functioning at any time point ( p values ranged 
between p = .20 and p = .96 for social functioning, and between p = .08 and p = .79 for role 
functioning) or with age at baseline (B = –0.05, SE = 0.04, p = .18). Table 1 presents 
baseline demographic and clinical data for the 358 CHR participants and the 164 healthy 
comparison subjects. CHR individuals overall had lower IQ, and were significantly more 
often White and male relative to the comparison group. CHR-NC individuals had fewer 
years of education and were younger than CHR-C and the control group.
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GF: Social functioning trajectories
The square of correlations between role and social functioning was .34, indicating a 
moderate amount of common variance. We examined the natural course of social 
functioning by examining the social functioning data over time in controls. Social 
functioning in this group was dynamic, gradually improving with age (B = 0.08, SE = 0.02, 
p ≤ .001). Both the CHR-C and CHR-NC groups had lower levels of social functioning over 
time relative to the control group (main effect: B = –2.84, SE = 0.17, p < .001; B = –2.04; 
SE = 0.12, p < .001). There was a trend toward a Group×Age interaction when comparing 
functional trajectories across all groups (B = –0.10, SE = 0.06, p = .073), suggesting that 
functional trajectories may differ between groups. Examining this further, we observed that 
in contrast to CHR-NC individuals who (in congruence with the healthy control sample) 
significantly improved in their social functioning skills with age (B = 0.10, SE = 0.02; p < .
001), the CHR-C group did not show such an increase (B = –0.0002, SE = 0.06, p = .997; 
see Figure 1). These findings held when the baseline severity of positive, negative, and 
disorganized symptoms were accounted for.
Analyses within the CHR group suggest that there may be two potential periods during 
which converters started to lag behind in social functioning compared to nonconverters (see 
Table 2). Between ages 15 and 18, the growth seen in premorbid social functioning of 
nonconverters was not seen in the converting group (B = –0.84, SE = 0.25, p = .001; Cohen 
d = 0.56). Subsequently, a similar period occurred between ages 21 and 23, reflected by a 
relatively increasing deficit between converters and from nonconverters (B = –1.53, SE = 
0.38; p < .001; Cohen d = 1.07). Controlling for prodromal symptoms did not attenuate the 
results.
GF: Role functioning trajectories
Similarly, in the domain of role functioning, controls marginally improved with age (B = 
0.04, SE = 0.02, p = .04). Although an overall group difference was apparent (with the CHR-
C and CHR-NC groups having lower role functioning scores compared to the control group; 
main effect: B = –2.75, SE = 0.20, p < .001; B = –2.05; SE = 0.14, p < .001), here there was 
no indication of a Group × Age interaction. Adjusting the analyses for prodromal symptom 
severity at baseline did not alter the results.
However, examining the developmental trajectories per group separately, we found the 
CHR-C group to show greater impairment in role functioning compared to CHR-NC 
between ages 12 and 15 (B = –1.60; SE = 0.55; p = .004; Co-hen d = 0.81). In addition, we 
detected a similar difference for role functioning between CHR-C and CHR-NC as observed 
for the social trajectories (see Figure 1) between the ages of 21 and 23 (B = –0.94, SE = 
0.37, p = .01; Cohen d = 0.83). This latter effect decreased to trend level when negative 
symptoms or disorganization symptoms were accounted for (B = 0.74; SE = 0.45, p = .08, 
and B = –0.78, SE = 0.45, p = .059, respectively).
Converters and nonconverters between ages 21 and 23 were otherwise largely comparable to 
those with data at earlier ages. Apart from a higher IQ score in nonconverters age 21–23 
compared to the nonconverters in the younger group (IQ = 106.0 vs. IQ = 113.4; p = .02), 
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the CHR-C and CHR-NC groups with data between ages 21 and 23 did not significantly 
differ from the those with data at earlier ages in terms of positive, negative, general, or 
disorganization symptoms, nor in terms of ethnicity or gender.
Discussion
In a large sample of youth at high clinical risk for psychosis, we evaluated whether there are 
periods of change in the development of two key components of community functioning: 
social and role functioning. Taken together, our results indicate that both social and role 
functioning are more impaired in CHR individuals compared to controls from as early as age 
12, and that differences between converters and nonconverters become increasingly apparent 
by age.
In congruence with the literature (Shapiro et al., 2009), functional levels of controls 
gradually increased with age. For social functioning, there were periods of early and late 
dynamic changes that distinguished CHR-C from CHR-NC, and results remained consistent 
when time to conversion was accounted for. During the first period, between ages 15 and 18, 
social functioning of converters stagnated and diverged from that of nonconverters, who, like 
controls, continued to improve. Next, the growth seen in nonconverters between ages 21 and 
23 was not apparent for converters, further distinguishing them from nonconverters. Similar 
changes were observed for role functioning, with functioning levels that were lower in the 
CHR cohort, but initially increasing in a similar pace for both converters and nonconverters 
relative to the functional improvement observed in controls. However, a late change in role 
functioning became apparent for the converter group, as their role functioning scores seemed 
to stagnate between ages 21 and 23.
Similar patterns have been observed in a cross-sectional cohort (Velthorst et al., 2015) and in 
various retrospective studies to patients diagnosed with schizophrenia using the Premorbid 
Adjustment Scale (Allen et al., 2005; Monte et al., 2008; Shapiro et al., 2009; Strauss et al., 
2012). The initial more pronounced difference in trajectories for social functioning between 
converters and nonconverters may be at least partly explained by findings of previous work 
from our research group, showing that social and role functional outcome may be driven by 
different cognitive functions (Carrion et al., 2013; Meyer et al., 2014). In this study, 
processing speed performance appeared to be particularly important for social outcome, 
while verbal memory was found more strongly related to successful academic and work 
achievement. Population-based studies point to an accelerated deficit in processing speed 
from the age of 13 in children who will develop adult schizophrenia, which could explain 
the stagnation in social functioning around that time (Meier et al., 2014; Reichenberg et al., 
2010). In contrast, impairment in verbal memory has been found to be more stable (Stone et 
al., 2016), possibly accounting for the initially more subtle deficits in role functioning.
As argued previously, although accounting for baseline prodromal symptom severity did not 
alter our results, the subsequent period of stagnation in both social and role functioning in 
early adulthood may be caused by the interaction between prodromal symptoms and the 
increasingly complexity of social and work tasks that have to be taken on (Hafner et al., 
1999; Velthorst et al., 2009). While in early adolescence support systems may still 
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compensate and hide subtle functional deficits, early adulthood represents a phase during 
which people are no longer expected to heavily rely on others, potentially contributing to the 
increasing deficits during this time. It will be interesting for future studies to disentangle 
how stagnation in functional impairment may in turn directly contribute to increased risk of 
psychosis onset in the CHR samples; for example, it may be that functional impairment 
creates social distress, or reduces access to social support.
This study has several limitations. First, the minimum age of study participants was 12. We 
are therefore constrained to conclusions about functional trajectories, and symptom 
development only from this age onward. It would be interesting for future prospective 
population-based cohort studies to examine at which age first symptoms and functional 
impairments appear. Second, “a significant drop in functioning” was one of the necessary 
criteria for individuals included based on schizotypal personality disorder diagnosis. 
However, in our study only 0.8% of the CHR individuals were included solely based on the 
criterion “first-degree relative with psychosis or patient with schizotypal personality disorder 
and a 30% drop in global assessment of functioning score compared with that 1 year ago, 
sustained over the past month,” and omitting those subjects from the analyses did not 
significantly impact the results. Third, many, but not all, individuals who go on to develop 
psychosis experience subthreshold symptoms, and our conclusions are limited to those who 
do. In addition, some CHR subjects may convert to psychosis after the 2.5-year follow-up 
period (Nelson et al., 2013), and some converters may only have experienced brief full-
blown psychotic complaints. Fourth, the potential misclassification of some subjects may 
have reduced differences observed between converters and nonconverters (Seidman et al., 
2010). Because controls with DSM-IV psychiatric diagnosis were excluded, the control 
group may represent a higher functioning subgroup of the general population. However, the 
divergence in functioning we observed between CHR-C and CHR-NC would suggest that 
our findings are not simply a result of general distress, but are related to subsequent 
development of psychosis. Fifth, the sample size of converters in the 12–15 and 21–23 age 
bands was relatively small, and findings with regard to these age epochs should be 
interpreted with caution. Sixth, the lack of an association between time to conversion and 
functioning scores may have been partly accounted for by limited variability in the time to 
conversion, with the majority converting within the first year. Seventh, data on ongoing 
(pharmacological) interventions was not taken into account.
Despite these limitations, our study is largely consistent with results of previous studies, 
which suggest that early stagnation in social functioning may be a unique risk marker for 
psychosis (e.g., Cannon et al., 2008; Strauss et al., 2012; Velthorst et al., 2010). Our findings 
also provide new evidence supporting the neurodevelopmental model of psychosis, pointing 
to a developmental lag in social functioning between the ages of 15 and 18, followed 
byanother period of stagnation in earlyadulthood. Results we found related to age rather than 
to greater levels of functional impairment in those closer to overt illness. Role functioning 
trajectories of converters and nonconverters were initially more comparable, although also 
for role functioning, a period of relatively increasing impairment in early adulthood became 
apparent for the converting group.
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Moreover, our findings further highlight the importance of examining social and role 
functioning separately, and moving away from “global” measures to more age-specific 
measures (Cornblatt et al., 2007). Treatment attempts to improve social functioning in 
psychotic disorders have been only marginally successful (Almerie et al., 2015), which may 
be partly due to the global measures used, as well as our limited knowledge of when 
deviations develop. Our results indicate that impaired social and role functioning in CHR 
individuals are apparent already in early adolescence, but that functioning levels of 
converters further diverge from nonconverters in early adulthood. We found middle 
adolescence to be a first period of change in the development of social functioning, as during 
this time trajectories of those with and without a psychotic disorder start to diverge. 
Worldwide, noninvasive cognitive (behavioral) interventions for young individuals at risk for 
psychosis are emerging (Addington, Epstein, et al., 2011; Landa et al., 2016; Okuzawa et al., 
2014; van der Gaag et al., 2012, 2013) with few also focusing on the improvement of social 
functioning, or the preservation of social engagement (for a review, see Thompson et al., 
2015). Certain cognitive interventions (e.g., see French & Morrison, 2004) may be 
promising in impeding the deteriorating functional course of adolescents at risk for 
psychosis.
It will be important for future studies to disentangle what neural and genetic processes 
contribute to this diversion and how these processes vary across different functions. The 
significance of these future studies has been highlighted by Hodgekins et al. (2015) who 
found that a large proportion of individuals with significant social disability do not improve 
over the first 12 months of service provision (66%).
Conclusion
In conclusion, our findings provide new insight into the developmental course of functioning 
in youth at CHR for psychosis, and inform the field about potentially important intervention 
windows. We hope that a better understanding of the origins and developmental course of 
functional impairment will ultimately help us decrease its debilitating consequences and 
increase our knowledge of the pathways to psychotic disorders.
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Figure 1. 
(Color online) Developmental trajectories of social and role functioning. The Y-axis in the 
figure represents the GF: Social Scale and the GF: Role Scale scores, which range from 1 to 
10, with higher scores meaning better functioning. The X-axis represents mean scores at the 
assessments conducted with individuals at ages 12–15, 15–18, 18–21, and 21–23.
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Table 1
Baseline demographic and clinical characteristics of the sample
Variable
CHR
Controls (n = 164) Statistics*Converters (n = 83) Nonconverters (n = 275)
Gender, no male (%) 59 (69.9) 175 (63.3) 77 (47.0) 1, 2 > 3
Age at baseline, mean (SD) 17.98 (2.51) 16.86 (2.90) 17.91 (3.25) 1, 3 > 2
White,a n (%) 55 (68.75) 192 (73.28) 96 (61.54) 1, 2 > 3
IQ at baseline, mean (SD) 102.72 (19.65) 106.72 (15.99) 111.51 (13.46) 1, 2 < 3
Years of education, mean (SD) 10.86 (2.02) 9.85 (2.68) 10.95 (2.94) 1, 3 > 2
Lower educational level father,b n (%) 17 (35.42) 54 (29.83) 19 (14.62) 1, 2 > 3
GF
 Social, mean (SD) 5.49 (1.43) 6.21 (1.50) 8.61 (0.99) 1 < 2 < 3
 Role, mean (SD) 5.45 (1.74) 6.12 (1.88) 8.62 (0.97) 1 < 2 < 3
SIPS
 Positive symptoms 14.00 (4.58) 10.77 (3.92) 0.89 (1.58) 1 > 2 > 3
 Negative symptoms 15.31 (6.87) 11.70 (6.54) 0.97 (1.62) 1 > 2 > 3
 Disorganized symptoms 8.25 (4.57) 5.51 (3.50) 0.39 (0.77) 1 > 2 > 3
 General symptoms 9.38 (4.46) 7.57 (4.05) 0.61 (1.05) 1 > 2 > 3
Note: CHR, Clinical high risk; GF, global functioning; SIPS, Structured Interview for Prodromal Syndromes. Scores represent SIPS and GF at 
baseline.
a
Data for n = 24 missing.
bNumber of individuals without education higher than high school. Data for n = 163 missing.
*p = .05.
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